Wednesday, April 29, 2020

Strides Pharma Science Ltd – Drug to treat Covid-19 ( Now Available at Discount )

Strides Pharma Science Ltd  closes   at  449.10  with  a  Gain     of    + 20 %   on    29-April-2020   with formation of  a  Green  Candle    on Daily  Price Chart.
Why to Consider it ?  The Company is to apply to Indian Drug Authorities to start necessary studies and make the drug available to patients in the country expeditiously for Covid-19.
Source : Media News
Valuations  : We are expecting that company will  post PAT of Rs. 262.10 Cr in FY2020  , Rs.345.6 Cr in FY 2021 & Rs. 434.80 Cr in FY 2022.
Company is now Trading at X1.3 of its Value. If we consider the above earning , it is Trading at X0.95 of its FY20 earnings ( Discount of ~5% ) & X0.72 of its FY21 earnings ( Discount of ~28% and X0.57 of its FY2020 ( Discount of ~47% )
Disclaimer : We are / may going to take exposure shortly.
Join Us at   Telegram #
Data Source | NSE Website | Screener.In  | Capital Line | Money Control |
The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

No comments:

Post a Comment

Thanks for Your Valuable comments. It will make Us to Serve You in Better Way. For Any STOCKS Query ,Please Call NiftyNext +91 880 2230 836.


The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.

Blog Archive